Ultraviolet radiation (UVR) is a strong and ubiquitous risk factor for cutaneous melanoma, emitted naturally by the sun but also artificial sources. To shed light on the potential impact of interventions seeking to reduce exposure to UVR in both high and low risk populations, we quantified the number of cutaneous melanomas attributable to UVR worldwide. Population attributable fractions and numbers of new melanoma cases in adults due to ambient UVR were calculated by age and sex for 153 countries by comparing the current melanoma burden with historical data, i.e., the melanoma burden observed in a population with minimal exposure to UVR. Secondary analyses were performed using contemporary melanoma incidence rates in dark-skinned African populations with low UVR susceptibility as reference. Globally, an estimated 168,000 new melanoma cases were attributable to excess UVR in 2012, corresponding to 75.7% of all new melanoma cases and 1.2% of all new cancer cases. This burden was concentrated in very highly developed countries with 149,000 attributable cases and was most pronounced in Oceania, where 96% of all melanomas (representing 9.3% of the total cancer burden) were attributable to excess UVR. There would be approximately 151,000 fewer melanoma cases worldwide were incidence rates in every population equivalent to those observed in selected low-risk (dark-skinned, heavily pigmented) reference populations. These findings underline the need for public health action, an increasing awareness of melanoma and its risk factors, and the need to promote changes in behavior that decrease sun exposure at all ages.
Cutaneous malignant melanoma of the skin (hereafter "melanoma") is a tumor most commonly observed in fairskinned populations. With >230,000 new cases and 55,000 deaths estimated in the year 2012 globally, the burden is highest in Europe, Northern America and Oceania, where 87% of all new cases occur 1 ; heavily pigmented populations in Africa, the Indian subcontinent and Melanesia experience a considerably lower melanoma burden. Interestingly, melanoma rarely affects fair-skinned individuals of East Asian descent.
According to the IARC review of human carcinogens, ultraviolet radiation (UVR) is a strong causal risk factor for melanoma and keratinocyte skin cancer (basal and squamous cell carcinomas), 2,3 the latter being the most common group of human cancers observed in many countries. This evaluation is based on well-understood causal mechanisms linking UVR to cancer, but also on epidemiological studies that have reported continuous increases in skin cancer incidence over time and across populations. While melanoma rates in most European countries continue to rise, rates in Northern America and Oceania seem to have leveled off in recent years. [4] [5] [6] A strong cohort effect underlies these temporal variations in melanoma incidence in higher incidence populations, with rates stabilizing or in decline among recent generations in some countries. 4 This may be attributed largely to changes in lifestyle and social behavior that have led to decreases in sun exposure, possibly resulting from an increasing awareness of skin cancer and its prevention. Yet, the continual increases in risk observed in older age groups, coupled with ongoing demographic changes (population growth and aging), imply an ever-increasing number of melanoma diagnoses can be expected in the future, emphasizing the need for targeted melanoma control measures. 6 Quantifying the burden of cancer attributable to UVR exposure is important for cancer control planning and sheds light on the potential impact of interventions aiming to reduce exposure. To date only a few studies have estimated the population attributable fraction (PAF) for UVR at a national level. A U.K. study from reported that 86% of all melanoma cases, equivalent to 3.5% of all new cancer cases, were attributable to UVR exposure, 7 while in two Australian studies over 95% of all melanoma cases were estimated to be due to high ambient levels of UVR exposure. 8, 9 A recent analysis from Cali, Colombia, concluded that 62% of all melanomas among men and 19% among women were attributable to UVR exposure. 10 This study aims to quantify the global number of cases of cutaneous melanoma attributable to UVR exposure. Moreover, to assess the potential preventability of the disease and to promote lifestyle modifications that seek to reduce individual sun exposure and corresponding melanoma burden worldwide, we develop scenarios that assume rates could be reduced to those in low-risk reference populations, selected according to time or geography.
Material and Methods
The prevalence and intensity of UVR exposure is difficult to quantify at the population level. Ideally robust data would be available on ambient UV levels, duration and timing of being outdoors, use of sun protection and estimations of accumulated personal dose. As there are no populations, which are completely unexposed to sunlight, the traditional approach to quantifying PAFs-using population prevalence of exposure and corresponding relative risks of cancer-cannot be applied. Instead, we used an approach utilized in previous studies 7-9 that compares currently observed melanoma incidence rates with those of a "minimally exposed" reference population, attributing differences in new cases to corresponding differences in UVR exposure between the reference and study population.
National estimates of new cases of melanoma were obtained from GLOBOCAN 2012, 11 with only those countries with at least ten melanoma cases (in both sexes) included in the study (n 5 153, representing 96% of the estimated global melanoma burden). In our primary analysis, we estimated PAF as the proportional difference between estimated new cases by country, 5-year age group (ages 301) and sex for the year 2012 and the expected number of cases using incidence rates from the same reference population used by Parkin et al., a 1903 birth cohort resident in South Thames, U.K. 7 This cohort, generated by fitting an age-cohort model to reconstruct the 5-year age-specific incidence rates for age groups without observations, was chosen as reference given its minimal exposure to UVR; the cohort was resident in a high-latitude, low UVR environment in an era when clothing styles translated to almost complete skin coverage. We observed age-standardized incidence rates in this cohort of 1.0 and 1.9 per 100,000 person-years in men and women, respectively. The variance estimate of the PAF obtained via the delta method was used to compute 95% uncertainty estimates. 12 In secondary analyses, we estimated the fraction of melanomas that could have been avoided if all populations were to experience melanomas rates as low as those observed in three African cancer registries [Harare (Zimbabwe), Uganda (Kyadondo) and Malawi (Blantyre)] in 2003-2007. 13 Most sub-Saharan African populations are dark-skinned, heavily pigmented and characterized as having very low melanoma incidence rates, and therefore constitute a good reference to quantify excess melanoma burden due to UVR in other populations. For both scenarios, we used the following formula to calculate age-, sex-and country-specific PAF:
where I p is the incidence of melanoma in 2012 in the study populations, and I u is the incidence in the reference population. The number of cancer cases attributable to UVR exposure was also expressed as a percentage of the total number of all new cancer cases in 2012, excluding nonmelanoma skin cancers. The country-level PAF from the 153 countries under study were aggregated to obtain world region and global PAF estimates. As melanoma patterns in South Africa differ substantially from those observed in other sub-Saharan countries, PAF and attributable cases for this country were presented separately. Countries were also grouped into four categories according to the UN-defined cut-points of the Human Development Index (HDI) in 2012 (very high, high, moderate and low HDI).
Interactive tools for analyzing and visualizing the data presented in this article can be accessed at gco.iarc.fr/causes/ uv
Results
An estimated 168,000 new melanoma cases were attributed to excess exposure to UVR in 2012, representing 75.7% of all melanoma cases and 1.2% of the total cancer burden worldwide ( Table 1 ). The global burden was higher in men (95,000 attributable cases; 81.3% of all melanomas) than in women (73,000; 69.4%) and greatest in the age group 50-69, where almost half of all attributable cases occurred (76,000; 78.4%, both sexes). Furthermore, the vast majority of UVRattributable burden was concentrated in very high HDI countries, where 149,000 new cases or 86.6% of all melanomas due to excess UVR. In contrast, only about 3,000 attributable melanoma cases were estimated in low and medium HDI countries.
Region-specific estimates showed that North America contributed the largest proportion of attributable cases (38.6%, 64,900), followed by Western Europe (18.3%, 30,700), while relatively few melanoma cases were attributable to UV radiation in sub-Saharan Africa, Asia, the Middle East and Northern Africa and Latin America and the Caribbean (Table 1 and Fig. 1 ). The proportion of melanoma cases attributable to excess UVR exposure in adults aged over 30 varied widely across regions, ranging between 2 to 97% in men and 0 to 94% in women, with the lowest and highest PAF observed in East Asia and Oceania, respectively, in both sexes. While melanoma cases attributable to UV radiation represented 9.3% of all new cancer cases in Oceania (14.9% in the age Group 30-49 years) and 3.9% of all new cancer cases in Northern Europe (10.3% in the age Group 30-49 years), this proportion was negligible in Asia, Africa and Latin America (all 0.6%; Table 1 ).
Country-specific estimates of the proportion of melanoma and all cancer cases attributable to excess UVR exposure are illustrated in Figures 2 and 3 , respectively. In men, the highest PAF were observed in New Zealand and Australia, where 97.5% of all new melanoma cases were estimated to be attributable to UV radiation. In contrast, the PAF for melanoma was <5% in 25 included countries. Melanoma cases attributable to UVR exposure represented 11.6% and 10.0% of the overall cancer burden in men in New Zealand and Australia respectively, followed by Sweden and Switzerland (both 4.9%). In women, the highest PAF for melanoma was observed in New Zealand (94.9%), followed by Australia (94.0%) and Norway (90.3%). In New Zealand and Australia, melanoma cases attributable to UV radiation accounted for 10.6 and 8.9% of the total cancer burden in women, respectively.
Using the Sub-Saharan African populations as a reference, the PAF were somewhat lower, with 68.0% of all new melanoma cases attributable to UVR exposure, corresponding to 151,000 cases and 1.1% of the total global cancer burden in 2012 (Supporting Information Annex Table S1 ).
Discussion
Our study has estimated 168,000 new melanoma cases were attributable to excess exposure to UVR in 2012, representing three-quarters of the global burden from the disease and approximating one in every 100 cancer cases in adults (excluding nonmelanoma skin cancer diagnosis). While about 90% of all melanoma cases related to UVR exposure occurred in very highly developed countries, the fraction of attributable cases out of the total cancer burden was minimal in low and medium HDI countries. The highest PAF were observed in Australia and New Zealand, with PAF for melanoma exceeding 90%. In sensitivity analyses using incidence rates observed in sub-Saharan Africa as the reference, we observed slightly lower estimates of 151,000 attributable cases.
This study is the first to quantify the global melanoma burden attributable to UVR exposure. We used a similar approach to estimate PAF as previous studies from the UK, Australia and Colombia 7, 8, 10 that assumed melanoma cases beyond a reference level may be attributed to excess UVR exposure. This assumption implies that that the excess melanomas are caused by population changes in lifestyle, from sun avoidance towards sun-seeking behavior (e.g., more outdoor leisure activities, holidays spent in sunny location, use of artificial tanning devices). The results from the Australian and UK studies are in line with our findings for very high income countries, with predominantly Caucasian populations, with PAF close to or above 90%. 7, 8 Using the U.K. birth cohort data from 1903 as a reference in the main analysis, we assumed that melanomas arising at rates below these levels were not attributable to UVR exposure. These low melanoma incidence rates in the reference population are similar in magnitude to those observed in contemporary nonCaucasian, darker-skinned populations. 15 Numerous epidemiological and mechanistic studies have shown that UVR exposure is the most important risk factor for melanoma and non-melanoma skin cancers, as it is known to induce carcinogenic mutations and to suppress certain aspects of the immune system. 3 Recent molecular analyses have shown that the mutation burden of melanoma is the highest for all cancers, and is overwhelmingly due to UVR signature mutations in the DNA. 16 Generally, people at lower risk of developing melanoma have protective phenotypes related to UVR sensitivity, such as pigmented skin types and few freckles, as well as other linked factors including number of atypical nevi or sunbathing behavior. 17 Caucasians usually have a much higher risk of developing skin cancer owing to their relative lack of melanin. Melanoma has also been shown to depend not only on environmental, but also genetic influences with an estimated 10% of cutaneous melanomas occurring in a familial setting with two or more close relatives affected. 18 In recent years, substantial advances have been made in molecular and genetic research determining the predisposition and gene mutations related to melanoma.
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Mutations in the two main genes associated with melanoma (CDKN2A/p16 and CDK4) have been estimated to be responsible for 35-40% of familial melanomas. 20, 21 Furthermore, variants causing loss of function of the human melanocortin 1 receptor gene (MC1R), which plays a crucial role in human skin pigmentation, have been found to be increase the risk of melanoma. 22 Cutaneous melanoma has several pathological presentations, one of them, acral lentiginous melanomas (ALM)-occurring on the palms of the hands, plants of the feet and in the nailbeds-is thought to be unrelated to UVR. 23 While ALM forms only a negligible fraction of all melanomas in Caucasians, it represents the majority of melanomas in populations with deeper pigmentation. [23] [24] [25] [26] Yet, this type of melanoma is rare and incidence rates have been stable for the past decades, with few notable differences between fair-and dark-skinned populations. In the U.S., the incidence rate of ALM has been identical in Blacks and Non-Hispanic Whites over the past decades. 25 Under the assumption that, ALM incidence has not changed over time and has already been present in the 1903 birth cohort, no further adjustment was made for ALM in the PAF calculations.
Despite being largely preventable, melanoma is the most serious skin cancer worldwide due to its high potential for metastasis. Mortality rates range between 4.7 per 100,000 in New Zealand to <0.1 in many African and Asian countries, 11 with increasing or stabilizing trends as a result of increasing incidence in many high-income countries. [27] [28] [29] Survival from melanoma depends on the sex of the patient (superior female survival is consistently reported), pathological type, tumor thickness, body site and, most importantly, stage at diagnosis. 30 While 5-year survival estimates range between 83 and 93% in Europe 31 (1999-2007) respectively, and have continuously improved over the past decades, prognosis is estimated to be poorer in low and middle income settings. 33 Recent increases in the mortality from thin melanomas have been reported in both Australia 34 and the US, reinforcing the importance of prevention and early detection in high-income settings.
While UVR exposure from sunlight cannot be completely avoided, individual exposure to both solar and artificial UVR (through sunbeds, for example) can be easily modified and reduced. Evidence-based prevention campaigns recommend the avoidance of UVR exposure especially during childhood and adolescence, a susceptible period for UV carcinogenesis. 35 Furthermore, protection from UVR can be enhanced by appropriate clothing and the application of sun screen with a high protection factor. 36, 37 Simulation studies have shown that interventions aimed at protecting people during outdoor work and hobbies against the harmful effects of UVR exposure could lead to remarkable reductions in melanoma incidence. 38 While incidence rates recently started leveling off in some high-incidence countries such as Australia and the US, most notably in young adults, the long latent period from exposure to initiation of carcinogenesis and clinical presentation may explain ongoing increases in incidence in other high-risk countries. 4 Changes in sun-seeking behavior and increasing awareness about the disease and its determinants are assumed to be driving this trend. Yet given less than half of the melanomas diagnosed in the Middle East, North Africa and Latin America and the Caribbean were attributed to UVR equally indicates a need to investigate non-UVR melanoma risk factors to help prevention efforts in these populations.
Strengths and Limitations
This study is the first to quantify the global cancer burden attributable to UVR exposure using one common approach for all countries, taking into account differences across age and sex. Although assumptions are necessary in estimating PAF, our careful analyses made use of the best available national estimates of melanoma incidence and utilized rates from two suitable minimally exposed reference populations for comparative purposes: a U.K. birth cohort from 1903 and recent combined data from three Sub-Saharan African countries. However, data from low-incidence countries remains scarce and national incidence estimates may represent considerably heterogeneous populations, especially with regards to ethnicity, skin type and habits related to sun exposure, resulting in correspondingly heterogeneous melanoma risks. Data from South Africa and Zimbabwe for example show that the vast majority of melanoma cases occurred in white Caucasians and rather few among blacks, even when taking into account the possible bias of whites being more likely to be diagnosed and biopsied than blacks. 39, 40 In addition, the GLOBOCAN database quantifies the number of new cases and rates at the national level and the robustness of the estimates depends largely on the availability and quality of the source information, specifically the existence of complete, accurate and representative population-based cancer registry data, in a given country. Despite strong evidence of an association with UVR, we were not able to include keratinocyte skin cancers (basal and squamous cell carcinomas) in our analyses, as they are typically not registered. To our knowledge, global estimates of the incidence of these cancer types are not presently available. In any case, it is likely that the incidence of melanoma may be prone to underreporting in some parts of the world, either due to a lack of diagnostic facilities, or a lack of reporting of cases treated in out-patient settings. These artefacts may be offset by over-reporting and an increasing detection of thin melanomas, as reported in high-income settings, related to increased diagnostic scrutiny. [42] [43] [44] In line with this, data from the U.S. show melanoma incidence rates on the rise by as much as 6% per year over several decades, while mortality levels have remained stable or decreased, 32 possibly linked to overdiagnosis. The advent of skin cancer screening programs and improved detection technologies, as well as increasing awareness in the population have certainly contributed to these temporal patterns. Skin cancer screening in Germany 45 and other countries 46 have been shown to have a substantial impact on melanoma incidence, with only limited evidence of specific benefits resulting from screening, by way of a mortality reduction. Finally, UVR is emitted naturally from the sun but can also emerge from artificial sources including tanning devices, the use of which has also been causally linked to an increased risk of melanoma. 3 Nevertheless, as a result of the relatively low prevalence of tanning device use, the PAF for this association is negligible on the population level. 47 With at least one in 100 new cancer cases resulting from UVR exposure, this analysis has quantified the potential of primary prevention in reducing the burden from the disease. The large number of cases and underlying risk of UVR- related melanoma in very high HDI countries, most notably in Australia and New Zealand, underlines the practical potential of public health action to avoid further rises in the burden. Key interventions must include educational campaigns that promote an enhanced awareness of melanoma and the key contributors that modulate risk, and specific behavioral actions that will reduce risk in the general population. 
